CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 207 enrolled
Drug / intervention
botulinum toxin Type Abiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01608672
NCT01608672N/ACompleted
CompareCT.gov

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Allergan·observational·Posted May 31, 2012·Updated Apr 16, 2019

In Brief

An observational study evaluating botulinum toxin Type A for Glabellar Lines. Completed, enrolled 207 participants across 5 sites in 5 countries.

Detailed Summary

This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGlabellar Lines
CountriesAustralia, Brazil, Canada, France, United States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 31, 2012
Enrollment StartApr 1, 2012
Primary CompletionDec 31, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.1 years ago

Interventions

botulinum toxin Type Abiological

botulinum toxin Type A (BOTOX®) treatment to glabellar lines as prescribed by the Investigator over at least 5 years.